The TRPA1 Agonist, Methyl Syringate Suppresses Food Intake and Gastric Emptying

49Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Transient receptor potential channel ankryn 1 (TRPA1) expressed in the gastrointestinal tract is associated with gastric motility, gastric emptying, and food intake. In this study, we investigated the effects of methyl syringate, a specific and selective TRPA1 agonist, on food intake, gastric emptying, and gut hormone levels in imprinting control region (ICR) mice. The administration of methyl syringate suppressed cumulative food intake and gastric emptying. In addition, treatment with ruthenium red (RR), a general cation channel blocker, and HC-030031, a selective TRPA1 antagonist, inhibited methyl syringate-induced reduction of food intake and delayed gastric emptying in ICR mice. Methyl syringate also increased plasma peptide YY (PYY) levels, but not glucagon-like peptide-1 (GLP-1) levels. The elevation in PYY was blocked by treatment with RR and HC-030031. The present findings indicate that methyl syringate regulates food intake and gastric emptying through a TRPA1-mediated pathway and, by extension, can contribute to weight suppression. © 2013 Kim et al.

Cite

CITATION STYLE

APA

Kim, M. J., Son, H. J., Song, S. H., Jung, M., Kim, Y., & Rhyu, M. R. (2013). The TRPA1 Agonist, Methyl Syringate Suppresses Food Intake and Gastric Emptying. PLoS ONE, 8(8). https://doi.org/10.1371/journal.pone.0071603

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free